Four Rivers Bioenergy (FRBE) CORRESP Correspondence with SEC

MED-TECH SOLUTIONS, INC.

October 14, 2005

THE UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Division of Corporation Finance
Mail Stop 3561
100 F Street, NE
Washington, DC 20549

Attention: William A. Bennett, Esq.

Dear Mr. Bennett:

Re:	Med-Tech Solutions, Inc. (the “Company”)
	Registration Statement on Form SB-2 - 333-122352

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests acceleration of the effective date of its Registration Statement on Form SB-2 to 12:00 p.m. (Eastern Standard Time) on October 17, 2005, or as soon thereafter as is practicable.

In connection with the Company’s request for acceleration of the effective date of its Registration Statement on Form SB-2, the Company acknowledges that:

• Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
   
• The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
   
• The Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance. Please call with any questions.

Very truly yours,

MED-TECH SOLUTIONS, INC.

/s/ Mark A. McLeary
_____________________________
Mark A. McLeary
President and Chief Executive Officer

Suite 2200 – 1177 West Hastings Street
Vancouver, BC V6E 2K3
Tel: (604) 688-7526